Self-Serve Dialysis?
Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.
Read the full article » | Posted 05-10-2017
Related Articles
- University of North Carolina’s GENESIS project to make HD device the size of a cell phone Posted 09-12-2024
- Kamal Shah of NephroPlus Discusses Dalysis Innovations Posted 08-16-2024
- Global Wearable Artificial Kidney Market Expected to Grow Posted 07-12-2024
- Byonyks X1: a New, Small, Portable APD Machine Posted 06-14-2024